+499.5%
MRNA vs ZBH
-5.6%
+505.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ZBH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.9% | -1.4% | -1.8% |
| 7D | +5.5% | -2.8% | +8.3% | +6.9% |
| 30D | +158.7% | -0.1% | +158.8% | +161.4% |
| 3M | +182.1% | +13.4% | +168.7% | +176.8% |
| 6M | +151.8% | +3.0% | +148.8% | +151.8% |
| YTD | +393.6% | +9.7% | +383.9% | +385.8% |
| 1Y | +499.5% | -5.4% | +504.9% | +555.6% |
| All | +499.5% | -5.6% | +505.1% | +555.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ZBH.
Daily Out/Under-Performance
Portfolio return minus ZBH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ZBH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ZBH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling